Eiger BioPharmaceuticals, Inc. (EIGRQ)
USD 8.5
(6.25%)
USD 8.5
(6.25%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 14.99 Million USD | 38.82% |
| 2022 | 10.8 Million USD | 1.95% |
| 2021 | 10.59 Million USD | 1743.1% |
| 2020 | -645 Thousand USD | -32.72% |
| 2019 | -486 Thousand USD | -800.0% |
| 2018 | -54 Thousand USD | -31.71% |
| 2017 | -41 Thousand USD | -78.26% |
| 2016 | -23 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q1 | 3.81 Million USD | 78.5% |
| 2023 Q4 | 3.52 Million USD | 21.62% |
| 2023 FY | 14.99 Million USD | 38.82% |
| 2023 Q2 | 4.77 Million USD | 25.16% |
| 2023 Q3 | 2.89 Million USD | -39.29% |
| 2022 Q3 | 2.58 Million USD | -30.82% |
| 2022 Q1 | 2.35 Million USD | -22.92% |
| 2022 FY | 10.8 Million USD | 1.95% |
| 2022 Q4 | 2.13 Million USD | -17.28% |
| 2022 Q2 | 3.73 Million USD | 58.23% |
| 2021 Q4 | 3.05 Million USD | 21.05% |
| 2021 FY | 10.59 Million USD | 1743.1% |
| 2021 Q3 | 2.52 Million USD | 56.66% |
| 2021 Q2 | 1.61 Million USD | 0.0% |
| 2020 FY | -645 Thousand USD | -32.72% |
| 2019 FY | -486 Thousand USD | -800.0% |
| 2018 FY | -54 Thousand USD | -31.71% |
| 2017 FY | -41 Thousand USD | -78.26% |
| 2016 FY | -23 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 11.7 Million USD | -28.131% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 4794.42% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 31180.213% |
| Qrons Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 12171.533% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 87.407% |
| Adynxx, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 158.14% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -10575.445% |
| Arch Therapeutics, Inc. | -2439.00 USD | 615065.15% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -483426.757% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | -53.145% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -22719.803% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 44020.937% |
| Mesoblast Limited | -35.16 Million USD | 142.65% |
| Marizyme, Inc. | 457.7 Thousand USD | -3177.023% |
| Genus plc | 178.7 Million USD | 91.607% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 93.185% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -24004.072% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -3556.821% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 136454.545% |
| ContraFect Corporation | -154 Thousand USD | 9839.61% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 30098.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -19439.871% |
| IMV Inc. | -962.29 Thousand USD | 1658.665% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 3970.7% |
| MultiCell Technologies, Inc. | 49.32 USD | -30411497.729% |
| ONE Bio Corp. | 20.12 Million USD | 25.472% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 62.749% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -30572.802% |
| Q BioMed Inc. | -8988.00 USD | 166978.06% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 46.916% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 97344.554% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 66.186% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 1413.89% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -21327.143% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 302987.722% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 15481.223% |
| GB Sciences, Inc. | -624.00 USD | 2403785.897% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 17535.021% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 99.802% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 7211157.692% |
| Enzolytics Inc. | 30.7 Thousand USD | -48743.949% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -3009.033% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.1 Billion USD | 98.647% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 3015.201% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -2329.444% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 96.338% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 169465.402% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 17988.108% |
| Kadimastem Ltd | -630.13 Thousand USD | 2480.272% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -1418.147% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -56.061% |
| BioStem Technologies, Inc. | 15.42 Million USD | 2.761% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 126834.263% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -8395.129% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -8395.129% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -1005.189% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 51820.69% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -3232.793% |
| SYBLEU INC | 11.69 Thousand USD | -128140.424% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -225.499% |
| Bioxytran, Inc. | -8285.00 USD | 181138.021% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 4121.18% |
| Neutra Corp. | 14.33 Thousand USD | -104532.02% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 18391.463% |
| PureTech Health plc | -1.6 Million USD | 1035.683% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 1598.048% |
| IXICO plc | 3.27 Million USD | -358.685% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 2261.239% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 937.465% |
| CSL Limited | 7.7 Billion USD | 99.805% |
| Cellectis S.A. | 18 Thousand USD | -83227.778% |